Nanjing Sainuo Biopharmaceutical

Nanjing Sainuo Biopharmaceutical is a China-based pharmaceutical company focused on the development and production of peptide drugs and recombinant proteins. Founded in 1994 and headquartered in the Nanjing High-tech Zone, the company has established a robust portfolio of commercialized products targeting metabolic, digestive, and immune system disorders. Key products include Salmon Calcitonin for osteoporosis, Somatostatin for acute gastrointestinal bleeding, and recombinant human Teriparatide. The company maintains high-standard GMP manufacturing facilities for both chemical synthesis and biological fermentation. Nanjing Sainuo continues to expand its presence in the domestic Chinese market through a combination of internal R&D and specialized manufacturing capabilities.